Position：Executive Vice Chair of Pharmacy
Medical School：Zhejiang University School of Medicine, China
Academic Rank：Chief Pharmacist
Hospital pharmacy, sustained and/or controlled release, clinical pharmacokinetics, pharmacogenomics, molecular pharmaceutics.
Senior Member, Chinese Pharmaceutical Association
Member, Chinese Pharmacological Association
Dr. Xu has published more than 80 research articles or reviews, including 5 SCI papers as first author or corresponding author.
Xu DH, et al. Mitochondrial targeted doxorubicin derivatives delivered by ROS-responsive nanocarriers to breast tumor for overcoming of multidrug resistance. Pharm Dev Technol. 2020 Oct 18:1-9. (Correspond author)
Xu DH, et al. Reduced Toxicity of Liposomal Nitrogen Mustard Prodrug Formulation Activated by an Intracellular ROS Feedback Mechanism in Hematological Neoplasm Models. Mol Pharm. 2020 Feb 3;17(2):499-506. (Correspond author)
Xu DH, et al. Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells. Drug Dev Ind Pharm. 2019 Sep;45(9):1556-1564. (Correspond author)
88 Jiefang Road,Shangcheng District Hangzhou,China, 310009
1511 Jianghong Road,Binjiang District Hangzhou,China, 310014
300 Yuanju Road, Shangcheng DIstrict, Hangzhou
456 Qidi Road, Xiaoshan District, Hangzhou, China
1 Xihu Avenue, Shangcheng District, Hangzhou
Zijingang Campus of Zhejiang University, 866 Yuhangtang Road, Xihu District, Hangzhou
Please call +86-571-8971 3988 (8am-5pm, Monday through Friday)
Make an appointment online
The Second Affiliated Hospital
Zhejiang University School of Medicine
88 Jiefang Road, Hangzhou, China
The Needs of Patients and Customers Come First.
The Second Affiliated Hospital Zhejiang University School of Medicine
All Rights Reserved.